Could APO-varenicline and cytisine be solutions for the shortage of varenicline in Brazil?
Author:
Affiliation:
1. 1. Departamento de Clínicas Pediátricas e do Adulto (DECPA), Universidade Federal de Ouro Preto, Ouro Preto (MG) Brasil.
2. 2. Faculdade de Medicina, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre (RS) Brasil.
Publisher
Sociedade Brasileira de Pneumologia e Tisiologia
Reference25 articles.
1. 1. Aglio TC, Diniz V, Matos MFAV, Rosa PPC, Rath S. N-Nitrosaminas em medicamentos: um problema atual, uma realidade antiga. Quim Nova. 2022;45(8):959-976. https://doi.org/10.21577/0100-4042.20170894
2. 2. Pfizer Brasil [homepage on the Internet]. São Paulo: Pfizer; c2023 [updated 2021 June 9; cited 2023 May 1]. Comunicado Champix ® (tartarato de vareniclina). Available from: https://www.pfizer.com.br/noticias/ultimas-noticias/informacoes-comerciais/comunicado-champix-tartarato-de-vareniclina
3. 3. Pfizer [homepage on the Internet]. New York City: Pfizer; c2023 [updated 2021 Jul 16; cited 2023 May 1]. Pfizer Issues A Voluntary Nationwide Recall for Twelve Lots of CHANTIX® (varenicline) Tablets Due to N-Nitroso Varenicline Content. Available from: https://cdn.pfizer.com/pfizercom/2021-07/Chantix_Recall_Press_Release_July_16.pdf?NYA8sPPy_oQjjkm.cis2p9gy1_pn80H7
4. 4. Pfizer [homepage on the Internet]. New York City: Pfizer; c2023 [updated 2021 Jul 16; cited 2023 May 1]. Pfizer Expands Voluntary Nationwide Recall to include All Lots of CHANTIX® (varenicline) Tablets Due to N-Nitroso Varenicline Content. Available from: https://cdn.pfizer.com/pfizercom/2021-09/Press-Release-Chantix-All-Lots-16SEP21.pdf?JTi.179qjytJBu2MVYPYt.dWuN8ic5Vx
5. 5. Lang AE, Patel U, Fitzpatrick J, Lee T, McFarland M, Good CB. Association of the Chantix Recall With US Prescribing of Varenicline and Other Medications for Nicotine Dependence. JAMA Netw Open. 2023;6(2):e2254655. https://doi.org/10.1001/jamanetworkopen.2022.54655
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3